Evidence map›Paper›PMID 40978399›Full record

ArticleACS omega2025

Modulating Rheological Properties via Non-Cross-Linked Phase in Biphasic Hyaluronic Acid Fillers.

Orhan Gokalp Buyukuysal, Zeynep Caglar, Alkin Ozgen, Halil Murat Aydin

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Orhan Gokalp BuyukuysalInstitute of Science, Bioengineering Division, Hacettepe University, Beytepe, Ankara 06800, Turkey.ORCID https://orcid.org/0000-0003-3597-3083
Zeynep CaglarInstitute of Science, Bioengineering Division, Hacettepe University, Beytepe, Ankara 06800, Turkey.ORCID https://orcid.org/0000-0001-7675-6152
Alkin OzgenInstitute of Science, Bioengineering Division, Hacettepe University, Beytepe, Ankara 06800, Turkey.ORCID https://orcid.org/0009-0001-3593-7608
Halil Murat AydinInstitute of Science, Bioengineering Division, Hacettepe University, Beytepe, Ankara 06800, Turkey.ORCID https://orcid.org/0000-0002-0732-1785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronic acid (HA) based soft tissue augmentation materials are high-value-added products that have been used as filling materials in many areas such as the chin, face, and hands for many years. In our study, the synthesis methodology that utilizes a less toxic cross-linker to obtain stiffer gels with a high storage modulus (G') leads to much safer dermal fillers. For this purpose, citric acid (CA) was used as a green cross-linker. By altering the amount of CA, a series of non-cross-linked gels were prepared and reconstituted with a size-reduced cross-linked phase to prepare biphasic hyaluronic acid fillers with different mechanical and rheological characteristics. The effect of steam sterilization on the biphasic gels' physical properties was examined. No toxic waste was encountered after steam sterilization in the biphasic gels. Non-cross-linked HA fractions with a concentration of 23 mg/mL and containing 4% (w/w), 6% (w/w), 8% (w/w), 10% (w/w), and 12% (w/w) amounts of CA were prepared. 1,4-Butanediol diglycidyl ether (BDDE) was used at 6% (w/w) concentration for cross-linked hyaluronic acid (CL-HA) gel synthesis. The BP-E-10-S sample was determined as the optimal group. Rheological results of the BP-E-10-S sample such as elastic modulus (G', Pa), loss modulus (G″, Pa), complex viscosity (η*), and phase angle (○) were measured 388.76 ± 13.91, 88.89 ± 6.22, 12.69 ± 0.47, and 12.86 ± 0.45, respectively. Cell viability was evaluated by an MTT assay using L929 cells.

Identifiers

PMID40978399
PMCPMC12444562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.